Ofev (Nintedanib) Seen to Be Safe and Effective Over Long-Term in IPF Patients
Long-term treatment of idiopathic pulmonary fibrosis (IPF) patients with Ofev (nintedanib) showed positive effects in keeping disease progression at bay, while inducing manageable side effects, Boehringer Ingelheim Pharmaceuticals announced. This finding comes from the INPULSIS-ON clinical trial  — an extension study of the INPULSIS trial — designed to assess the long-term effects of…